Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

David Kroll to Drug Interactions

This is a "connection" page, showing publications David Kroll has written about Drug Interactions.

 
Connection Strength
 
 
 
0.418
 
  1. Shaw HS, Kroll DJ. The convergence of herb pharmacodynamics and herb-drug interactions on hemostasis. Altern Ther Health Med. 2001 Nov-Dec; 7(6):46-7.
    View in: PubMed
    Score: 0.179
  2. Nebel A, Schneider BJ, Baker RK, Kroll DJ. Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother. 1999 Apr; 33(4):502.
    View in: PubMed
    Score: 0.150
  3. Kroll DJ. ASHP statement on the use of dietary supplements. Am J Health Syst Pharm. 2004 Aug 15; 61(16):1707-11.
    View in: PubMed
    Score: 0.054
  4. Ladas EJ, Kroll DJ, Oberlies NH, Cheng B, Ndao DH, Rheingold SR, Kelly KM. A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer. 2010 Jan 15; 116(2):506-13.
    View in: PubMed
    Score: 0.020
  5. Basch E, Bent S, Foppa I, Haskmi S, Kroll D, Mele M, Szapary P, Ulbricht C, Vora M, Yong S. Marigold (Calendula officinalis L.): an evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother. 2006; 6(3-4):135-59.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)